Synapse - Craig Moskowitz

Results (407)

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

Journal Article

Omuro, A.; Correa, D. D.; Deangelis, L. M.; Moskowitz, C. H.; Matasar, M. J.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C. C.; more...
Blood (2015)

Fulltext@MSK | Save

PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study

Journal Article

Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
Lancet Oncology (2015)

Fulltext@MSK | Save

Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma

Journal Article

Illidge, T.; Bouabdallah, R.; Chen, R.; Gopal, A. K.; Moskowitz, C. H.; Ramchandren, R.; Shustov, A. R.; Tilly, H.; Trippett, T. M.; Gibb, A.; more...
Leukemia and Lymphoma (2015)

Fulltext@MSK | Save

Highlights in lymphoma from the 2014 European Hematology Association Congress

Journal Article

Moskowitz, C. H.
Clinical Advances in Hematology & Oncology (2014)

Fulltext@MSK | Save

A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Phase I results

Meeting Abstract

Lunning, M. A.; Ruan, J.; Nair, S.; Boruchov, A. M.; Byrne, R.; Gerecitano, J. F.; Hamlin, P. A.; Inserra, B.; Leonard, J.; Lynch, P.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A multicohort trial of the safety and efficacy of the PD-1 inhibitor MK-3475 in patients with hematologic malignancies

Meeting Abstract

Garcia-Manero, G.; Martinelli, G.; Zeidner, J. F.; Avigan, D.; Anderson, K. C.; Rag, V. R.; Moskowitz, C.; Zinzani, P. L.; Wu, D.; Emancipator, K.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Interim analysis of a phase 1, open-label, dose-escalation study of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL)

Meeting Abstract

Forero-Torres, A.; Moskowitz, C.; Advani, R. H.; Shah, B. D.; Kostic, A.; Albertson, T. M.; Sandalic, L.; Zhao, B. T.; Fanale, M. A.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Interim safety analysis: A phase I trial of high dose therapy and autologous stem cell transplantation followed by infusion of chimeric antigen receptor modified T-cells (19-28z CAR-T) directed against CD19+B-cells for relapsed and refractory aggressive B cell non-Hodgkin lymphoma (B-NHL)

Meeting Abstract

Sauter, C. S.; Riviere, I.; Bernal, Y. J.; Wang, X. Y.; Purdon, T. J.; Yoo, S.; Moskowitz, C. H.; Giralt, S.; Matasar, M. J.; Curran, K. J.; more...
Blood (2014)

Fulltext@MSK | Save

A comprehensive clinical next generation sequencing-based assay can impact hematopathologic diagnosis in a significant subset of patients with hematologic malignancies

Meeting Abstract

Pichardo, J. D.; Feldstein, J. T.; Arcila, M.; Batlevi, C.; Zelenetz, A. D.; Moskowitz, C. H.; Horwitz, S. M.; Tallman, M. S.; Stein, E. M.; Klimek, V. M.; more...
Blood (2014)

Fulltext@MSK | Save

PD-1 blockade with the monoclonal antibody pembrolizumab (MK-3475) in patients with classical Hodgkin lymphoma after brentuximab vedotin failure: Preliminary results from a phase 1b study (KEYNOTE-013)

Meeting Abstract

Moskowitz, C. H.; Ribrag, V.; Michot, J. M.; Martinelli, G.; Zinzani, P. L.; Gutierrez, M.; De Maeyer, G.; Jacob, A. G.; Giallella, K.; Anderson, J. W.; more...
Blood (2014)

Fulltext@MSK | Save